0950B |
Camphor, Blood |
0950SP |
Camphor, Serum/Plasma |
0970B |
Carbamazepine and Metabolite, Blood |
0970FL |
Carbamazepine and Metabolite, Fluid |
0970SP |
Carbamazepine and Metabolite, Serum/Plasma |
0970TI |
Carbamazepine and Metabolite, Tissue |
0971SP |
Carbamazepine and Metabolite - Free, Serum/Plasma |
0972SP |
Carbamazepine and Metabolite - Total/Free/Bound, Serum/Plasma |
0975SP |
Carbamazepine-10,11-Epoxide, Serum/Plasma |
0975U |
Carbamazepine-10,11-Epoxide, Urine |
0985B |
Carbinoxamine, Blood |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1000B |
Carboxy-, Met- and Sulf-Hemoglobin, Blood |
1002B |
Carbon Monoxide Exposure Biouptake Screen, Blood |
1005B |
Carbon Monoxide Profile, Blood |
1006B |
Carbon Monoxide - Iron Ratio Profile, Blood |
1006TI |
Carbon Monoxide - Iron Ratio Profile, Tissue |
1009B |
Carbon Monoxide Exposure, Blood |
1010B |
Carbon Tetrachloride, Blood |
1019B |
Carbrital Profile, Blood |
1019SP |
Carbrital Profile, Serum/Plasma |
1030B |
Carisoprodol and Metabolite, Blood |
1030FL |
Carisoprodol and Metabolite, Fluid |
1030SP |
Carisoprodol and Metabolite, Serum/Plasma |
1030U |
Carisoprodol and Metabolite, Urine |
1033ST |
Cathartic Laxatives Profile, Stool |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1044B |
Chloral Hydrate, Blood |
1044SP |
Chloral Hydrate, Serum/Plasma |
1044U |
Chloral Hydrate, Urine |
1056B |
Cenobamate, Blood |
1056SP |
Cenobamate, Serum/Plasma |
1070B |
Chlordane and Metabolites, Blood |
1070SP |
Chlordane and Metabolites, Serum/Plasma |
1110B |
Chlorobenzene, Blood |
1110SP |
Chlorobenzene, Serum/Plasma |
1111U |
Chlorobenzene Exposure (p-Chlorophenol), Urine |
1130B |
Chloroform, Blood |
1180B |
Chlorothiazide, Blood |
1180SP |
Chlorothiazide, Serum/Plasma |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1255B |
Chlorzoxazone, Blood |
1255SP |
Chlorzoxazone, Serum/Plasma |
1261B |
Chromium, Blood |
1261FL |
Chromium, Fluid |
1261H |
Chromium, Hair |
1261N |
Chromium, Nails |
1261R |
Chromium, RBCs |
1261SP |
Chromium, Serum/Plasma |
1261TI |
Chromium, Tissue |
1261U |
Chromium, Urine |
1265B |
Chromium and Cobalt, Blood |
1265SP |
Chromium and Cobalt, Serum/Plasma |
1265U |
Chromium and Cobalt, Urine |
1287B |
Clozapine and Metabolite, Blood |
1287FL |
Clozapine and Metabolite, Fluid |
1287SP |
Clozapine and Metabolite, Serum/Plasma |
1287TI |
Clozapine and Metabolite, Tissue |
1287U |
Clozapine and Metabolite, Urine |
1290B |
Cobalt, Blood |
1290FL |
Cobalt, Fluid |
1290H |
Cobalt, Hair |
1290N |
Cobalt, Nails |
1290R |
Cobalt, RBCs |
1290SP |
Cobalt, Serum/Plasma |
1290TI |
Cobalt, Tissue |
1290U |
Cobalt, Urine |
1290UH |
Cobalt, 24 Hour Urine |
1320B |
Colchicine, Blood |
1320SP |
Colchicine, Serum/Plasma |
1320TI |
Colchicine, Tissue |
1330B |
Copper, Blood |
1330FL |
Copper, Fluid |
1330H |
Copper, Hair |
1330R |
Copper, RBCs |
1330SP |
Copper, Serum/Plasma |
1330TI |
Copper, Tissue |
1330U |
Copper, Urine |
1333SP |
Copper - Free, Serum/Plasma |
1348U |
Creatinine, Urine Overview: Evaluate Extent of Urine Dilution or Concentration |
1380B |
Cyanide, Blood |
1405B |
Cyclobenzaprine, Blood |
1405FL |
Cyclobenzaprine, Fluid |
1405SP |
Cyclobenzaprine, Serum/Plasma |
1405TI |
Cyclobenzaprine, Tissue |
1405U |
Cyclobenzaprine, Urine |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
1415B |
Cyclosporine, Blood |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
2423B |
Comprehensive Volatiles Panel, Blood |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
4207B |
Canrenone (Spironolactone metabolite), Blood |
4207SP |
Canrenone (Spironolactone metabolite), Serum/Plasma |
8031U |
Child Drug Exposure Screen, Urine |
9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9142B |
Cyanide Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9401B |
Chloral Hydrate Screen, Blood |
9401SP |
Chloral Hydrate Screen, Serum/Plasma |
9401U |
Chloral Hydrate Screen, Urine |